Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
Catherine Wilson(University of Oregon), Jeff Settleman(Discovery Centre)
Cited by 142
Related Papers
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
|Cancer Research|2014|308
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
|Cancer Research|2014|145
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors
|Oncogene|2013|92
Complete <i>de novo</i> assembly and re-annotation of the zebrafish genome
|bioRxiv (Cold Spring Harbor Laboratory)|2025|2